End-of-day quote
Other stock markets
|
||
- SEK | - |
06-13 | Certain B Shares of ADDvise Group AB are subject to a Lock-Up Agreement Ending on 13-JUN-2024. | CI |
05-21 | ADDvise Group AB Receives Order Worth USD 1.4 Million | CI |
Chart calendar ADDvise Group AB (publ)
Upcoming events on ADDvise Group AB (publ)
Past events on ADDvise Group AB (publ)
02/05/2024 | Annual General Meeting |
18/04/2024 13:00 | Q1 2024 Earnings Call |
18/04/2024 06:45 | Q1 2024 Earnings Release |
11/03/2024 | Redeye Serial Acquirers Conference |
22/02/2024 13:00 | Q4 2023 Earnings Call |
22/02/2024 06:45 | Q4 2023 Earnings Release |
26/10/2023 13:00 | Q3 2023 Earnings Call |
26/10/2023 06:45 | Q3 2023 Earnings Release |
20/07/2023 12:00 | Q2 2023 Earnings Call |
20/07/2023 06:45 | Q2 2023 Earnings Release |
05/05/2023 10:00 | Annual General Meeting |
20/04/2023 12:00 | Q1 2023 Earnings Call |
19/04/2023 | Q1 2023 Earnings Release |
02/03/2023 | Q4 2022 Earnings Release |
27/10/2022 | Q3 2022 Earnings Release |
21/07/2022 | Interim 2022 Earnings Release |
05/05/2022 | Annual General Meeting |
21/04/2022 | Q1 2022 Earnings Release |
23/02/2022 | FY 2021 Earnings Release |
22/07/2021 | Interim 2021 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million SEK | Released Forecast Spread | 350 349 0.25% | 358 364 -1.51% | 466 470 -0.79% | 952 951 0.1% | 1 373 1 399 -1.86% | 1 791 |
EBITDA Million SEK | Released Forecast Spread | 30,7 32,0 -4.15% | 33,3 40,0 -16.71% | 57,1 63,6 -10.22% | 175 184 -4.84% | 419 421 -0.42% | 450 |
EBIT Million SEK | Released Forecast Spread | 18,6 22,0 -15.32% | 34,3 29,0 18.13% | 43,0 49,4 -12.86% | 157 134 17.55% | 317 316 0.22% | 365 |
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | 1,67 3,00 -44.27% | 17,9 14,0 27.55% | 7,66 25,2 -69.61% | 108 136 -20.42% | 164 186 -11.52% | 220 |
Net income Million SEK | Released Forecast Spread | 4,05 -1,00 504.5% | 14,6 12,0 21.98% | 2,81 19,0 -85.24% | 81,1 89,3 -9.2% | 104 124 -16.47% | 162 |
EPS SEK | Released Forecast Spread | 0,04 -0,01 500% | 0,11 0,10 10% | 0,02 0,11 -81.82% | 0,46 0,38 21.05% | 0,56 0,70 -20% | 0,70 |
Announcement Date | 20/02/20 | 25/02/21 | 24/02/22 | 23/02/23 | 22/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million SEK | Released Forecast Spread | 162 161 0.87% | 232 198 17.37% | 237 211 12.47% | 320 319 0.31% | 311 294 5.61% | 344 310 11.1% | 321 303 5.97% | 397 423 -6.15% | 413 436 -5.18% | 428 | 453 | 497 |
EBITDA Million SEK | Released Forecast Spread | 21,3 20,0 6.47% | 31,8 28,0 13.46% | 36,0 31,8 13.28% | 85,8 89,1 -3.64% | 84,2 64,9 29.74% | 122 70,2 73.22% | 93,6 83,0 12.83% | 115 122 -5.36% | 99,1 121 -17.8% | 101 | 117 | 133 |
EBIT Million SEK | Released Forecast Spread | 16,5 15,0 9.68% | 28,5 22,1 28.88% | 32,8 25,9 26.76% | 79,4 58,9 35% | 69,0 53,9 27.99% | 86,5 56,6 52.83% | 66,6 57,9 15.02% | 94,7 94,1 0.62% | 79,3 95,6 -17.01% | 80,3 | 96,0 | 110 |
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | 20,0 10,3 93.64% | 42,6 15,7 171.56% | 44,9 72,6 -38.18% | 44,5 42,8 3.98% | 24,8 16,3 52.15% | 51,1 29,6 72.68% | 43,9 62,1 -29.3% | 54,4 54,2 0.45% | 46,6 | 71,2 | 83,1 | |
Net income Million SEK | Released Forecast Spread | 19,1 8,18 132.8% | 33,9 12,5 172.23% | 28,1 57,6 -51.27% | 35,6 34,0 4.76% | 3,20 12,9 -75.19% | 34,8 23,5 48.11% | 29,9 50,2 -40.38% | 42,9 40,7 5.45% | 24,3 | 41,9 | 52,6 | |
EPS SEK | Released Forecast Spread | 0,00 0,04 - | 0,11 0,08 37.5% | 0,19 0,09 111.11% | 0,16 0,11 45.45% | 0,20 0,16 25% | 0,02 0,18 -88.89% | 0,19 0,19 0% | |||||
Announcement Date | 22/04/22 | 22/07/22 | 28/10/22 | 23/02/23 | 20/04/23 | 20/07/23 | 26/10/23 | 22/02/24 | 18/04/24 | - | - | - |
26/06/2024 | SCHOTT PHARMA AG & CO. KGAA: Q2 2024 Earnings Release |
04/07/2024 | MANI, INC.: Q3 2024 Earnings Release |
11/07/2024 06:00 | GERRESHEIMER AG: Q2 2024 Earnings Release |
12/07/2024 06:00 | ARJO AB: Q2 2024 Earnings Release |
12/07/2024 06:30 | XVIVO PERFUSION AB: Q2 2024 Earnings Release |
17/07/2024 | ABBOTT LABORATORIES: Q2 2024 Earnings Release (Projected) |
17/07/2024 | MEDMIX AG: Q2 2024 Earnings Release |
19/07/2024 06:00 | SARTORIUS STEDIM BIOTECH: Q2 2024 Earnings Release |
22/07/2024 | NEOGEN CORPORATION: Q4 2024 Earnings Release (Projected) |
23/07/2024 | CONMED CORPORATION: Q2 2024 Earnings Release (Projected) |
Past sector events for ADDvise Group AB (publ)
18/06/2024 12:00 | PATTERSON COMPANIES, INC.: Q4 2024 Earnings Release |
07/06/2024 08:14 | TAIDOC TECHNOLOGY CORPORATION: May 2024 Sales and Revenue Release |
05/06/2024 11:00 | MESA LABORATORIES, INC.: Q4 2024 Earnings Release |
27/05/2024 21:30 | FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED: Q4 2024 Earnings Release |
23/05/2024 11:45 | MEDTRONIC PLC: Q4 2024 Earnings Release |
22/05/2024 06:00 | YPSOMED HOLDING AG: Q4 2024 Earnings Release |
17/05/2024 09:19 | POLY MEDICURE LIMITED: Q4 2024 Earnings Release |
16/05/2024 07:00 | CONVATEC GROUP PLC: Q1 2024 Sales and Revenue Release - Trading Update |
15/05/2024 03:00 | HOYA CORPORATION: Q4 2023 Earnings Release |
14/05/2024 06:00 | AMBU A/S: Q2 2024 Earnings Release |
- Stock Market
- Equities
- ADDV A Stock
- Stock
- Calendar ADDvise Group AB (publ)